For instance, diphenyleneiodonium demonstrates significant anti-tumor activity in MYCN-amplified neuroblastoma by targeting MYCN-induced mitochondrial alterations and ROS production, thereby inducing apoptosis and suppressing tumor growth (173). This evidence concerns the gene MYCN and neuroblastoma.